430 related articles for article (PubMed ID: 29885044)
1. β-Cell secretory defects are present in pancreatic insufficient cystic fibrosis with 1-hour oral glucose tolerance test glucose ≥155 mg/dL.
Nyirjesy SC; Sheikh S; Hadjiliadis D; De Leon DD; Peleckis AJ; Eiel JN; Kubrak C; Stefanovski D; Rubenstein RC; Rickels MR; Kelly A
Pediatr Diabetes; 2018 Nov; 19(7):1173-1182. PubMed ID: 29885044
[TBL] [Abstract][Full Text] [Related]
2. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
[TBL] [Abstract][Full Text] [Related]
3. Early-phase insulin secretion during mixed-meal tolerance testing predicts β-cell function and secretory capacity in cystic fibrosis.
Sheikh S; Stefanovski D; Kilberg MJ; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
Front Endocrinol (Lausanne); 2024; 15():1340346. PubMed ID: 38444582
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated insulin in pancreatic insufficient cystic fibrosis with post-prandial hypoglycemia.
Kilberg MJ; Sheikh S; Stefanovski D; Kubrak C; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
J Cyst Fibros; 2020 Mar; 19(2):310-315. PubMed ID: 31402215
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
[TBL] [Abstract][Full Text] [Related]
6. Effect of Sitagliptin on Islet Function in Pancreatic Insufficient Cystic Fibrosis With Abnormal Glucose Tolerance.
Kelly A; Sheikh S; Stefanovski D; Peleckis AJ; Nyirjesy SC; Eiel JN; Sidhaye A; Localio R; Gallop R; De Leon DD; Hadjiliadis D; Rubenstein RC; Rickels MR
J Clin Endocrinol Metab; 2021 Aug; 106(9):2617-2634. PubMed ID: 34406395
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of glucose intolerance in cystic fibrosis.
Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
[TBL] [Abstract][Full Text] [Related]
8. Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function.
Piona C; Volpi S; Zusi C; Mozzillo E; Tosco A; Franzese A; Raia V; Boselli ML; Trombetta M; Cipolli M; Bonadonna RC; Maffeis C
J Clin Endocrinol Metab; 2021 Mar; 106(4):e1793-e1802. PubMed ID: 33331877
[TBL] [Abstract][Full Text] [Related]
9. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
[TBL] [Abstract][Full Text] [Related]
11. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
[TBL] [Abstract][Full Text] [Related]
12. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
[TBL] [Abstract][Full Text] [Related]
14. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
[TBL] [Abstract][Full Text] [Related]
15. Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study.
Nielsen BU; Mathiesen IHM; Møller R; Krogh-Madsen R; Katzenstein TL; Pressler T; Shaw JAM; Ritz C; Rickels MR; Stefanovski D; Almdal TP; Faurholt-Jepsen D
Front Endocrinol (Lausanne); 2023; 14():1249876. PubMed ID: 37720541
[TBL] [Abstract][Full Text] [Related]
16. Preservation of β-cell Function in Pancreatic Insufficient Cystic Fibrosis With Highly Effective CFTR Modulator Therapy.
Flatt AJ; Sheikh S; Peleckis AJ; Alvarado P; Hadjiliadis D; Stefanovski D; Gallop RJ; Rubenstein RC; Kelly A; Rickels MR
J Clin Endocrinol Metab; 2023 Dec; 109(1):151-160. PubMed ID: 37503734
[TBL] [Abstract][Full Text] [Related]
17. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
18. Predictors for future cystic fibrosis-related diabetes by oral glucose tolerance test.
Schmid K; Fink K; Holl RW; Hebestreit H; Ballmann M
J Cyst Fibros; 2014 Jan; 13(1):80-5. PubMed ID: 23809507
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Continuous Glucose Monitoring in Cystic Fibrosis Patients With or Without Pancreatic Exocrine Insufficiency.
Rakotoarisoa L; Weiss L; Lefebvre F; Porzio M; Ravoninjatovo B; Abely M; Boucher ID; Dubois S; Troussier F; Gilles R; Prevotat A; Kessler L
Horm Metab Res; 2022 Jun; 54(6):407-412. PubMed ID: 35272389
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
